InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
50%
T+90 mean return
-2.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Fridriksdottir Hafrun, Vice-Président Exécutif. Insider active across 1 company, notably Teva Pharmaceutical Industries Ltd. In total, 9 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €1.9m. History available since 10 August 2021. The latest transaction was disclosed on 17 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
▼
130,000 shares@ US$8.21590.0028% mcap54.0% of flowOrdinary SharesSEC:0001209191-22-030308:0
51,488 sharesOrdinary SharesSEC:0001209191-22-017046:0
21,682 sharesOrdinary SharesSEC:0001209191-22-014469:0
16,121 sharesOrdinary SharesSEC:0001209191-22-008415:0
16,121 sharesOrdinary SharesSEC:0001209191-22-008415
▼
50,860 shares@ US$9.94930.0012% mcap23.0% of flowOrdinary SharesSEC:0001209191-21-051075:0
▼
50,860 shares@ US$9.949323.0% of flowOrdinary SharesSEC:0001209191-21-051075
37,884 sharesOrdinary SharesSEC:0001209191-21-032252
37,884 sharesOrdinary SharesSEC:0001209191-21-032252:0
9 of 9 declarations
About Fridriksdottir Hafrun
Hafrun Fridriksdottir is Executive Vice President, Global R&D at Teva Pharmaceutical Industries Ltd. She plays a key role in innovation and the development of new products, contributing to the company's mission to provide health solutions.
